Establishment of the first WHO International Standard for antiserum to Respiratory Syncytial Virus: Report of an international collaborative study

Respiratory Syncytial Virus (RSV), a leading cause of lower respiratory tract illness, has been a focus of vaccine development efforts in recent years. RSV neutralisation assays are particularly useful in the evaluation of immunogenicity of RSV vaccine candidates. Here we report a collaborative stud...

Descripción completa

Detalles Bibliográficos
Autores principales: McDonald, Jacqueline U., Rigsby, Peter, Dougall, Thomas, Engelhardt, Othmar G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838659/
https://www.ncbi.nlm.nih.gov/pubmed/30389194
http://dx.doi.org/10.1016/j.vaccine.2018.10.087

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838659/
https://www.ncbi.nlm.nih.gov/pubmed/30389194
http://dx.doi.org/10.1016/j.vaccine.2018.10.087

Ejemplares similares